Trials to treatments: repurposed drugs

What if a diabetes drug could slow down Parkinson’s, or a dementia drug could reduce falls? In this blog, we find out what drug repurposing means and take a look at drugs with potential for Parkinson’s.

Claire Bale
Aug 6, 2018 · 11 min read

Diabetes drugs are leading the way

Exenatide (also known as Bydureon or Byetta)

New kids on the block: lixisenatide and liraglutide

More repurposed drugs in trials for Parkinson’s

Cholesterol-lowering drugs: statins

A liver drug: UDCA

A cancer drug: nilotinib

An iron-removal drug: deferiprone

A blood pressure medication: isradipine

A cough medicine: ambroxol

A dementia drug: rivastigmine


More to come from repurposing


Parkinson’s UK

Get the latest research news, discover more about Parkinson’s and read about how others are getting involved. For information and support, visit www.parkinsons.org.uk

Claire Bale

Written by

Head of Research Communications and Engagement, Parkinson’s UK

Parkinson’s UK

Get the latest research news, discover more about Parkinson’s and read about how others are getting involved. For information and support, visit www.parkinsons.org.uk